Viemed Healthcare, Inc. (VMD)
NASDAQ: VMD · Real-Time Price · USD
8.94
-0.18 (-1.97%)
Aug 19, 2026, 4:00 PM EDT - Market closed
Viemed Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 301.61 | 270.28 | 224.26 | 183.01 | 138.83 | 117.06 | |
Revenue Growth | 25.21% | 20.52% | 22.54% | 31.82% | 18.60% | -10.85% |
Cost of Revenue | 128.28 | 114.82 | 91.05 | 70.23 | 54.15 | 43.65 |
Gross Profit | 173.32 | 155.46 | 133.2 | 112.78 | 84.68 | 73.41 |
Selling, General & Admin | 135 | 120.24 | 105.85 | 87.88 | 68.16 | 54.89 |
Research & Development | 2.46 | 3.02 | 3.07 | 2.78 | 2.7 | 2.11 |
Other Operating Expenses | -0.21 | -0.25 | -0.73 | -0.1 | -0.79 | -0.12 |
Operating Expenses | 147.77 | 133.62 | 115.95 | 97.81 | 76.28 | 62.88 |
Operating Income | 25.55 | 21.83 | 17.25 | 14.98 | 8.4 | 10.53 |
Interest Expense | -1.42 | -1.18 | -0.78 | -0.42 | -0.2 | -0.32 |
Interest & Investment Income | - | - | - | 0.49 | 0.94 | - |
Earnings From Equity Investments | - | - | - | - | - | 1.24 |
EBT Excluding Unusual Items | 24.13 | 20.65 | 16.47 | 15.04 | 9.14 | 11.45 |
Merger & Restructuring Charges | -1.06 | -1.12 | -0.35 | - | - | - |
Gain (Loss) on Sale of Investments | -0.16 | - | -0.95 | - | - | - |
Gain (Loss) on Sale of Assets | -1.72 | 2.24 | 1.91 | -0.65 | -0.35 | -0.45 |
Other Unusual Items | - | - | -0.9 | - | 0.2 | 1.5 |
Pretax Income | 21.18 | 21.77 | 16.17 | 14.39 | 8.99 | 12.5 |
Income Tax Expense | 6.16 | 6.39 | 4.76 | 4.15 | 2.77 | 3.38 |
Earnings From Continuing Operations | 15.03 | 15.38 | 11.41 | 10.24 | 6.22 | 9.13 |
Minority Interest in Earnings | -0.53 | -0.44 | -0.14 | - | - | - |
Net Income | 14.5 | 14.93 | 11.27 | 10.24 | 6.22 | 9.13 |
Net Income to Common | 14.5 | 14.93 | 11.27 | 10.24 | 6.22 | 9.13 |
Net Income Growth | 3.74% | 32.57% | 9.98% | 64.63% | -31.82% | -71.06% |
Shares Outstanding (Basic) | 38 | 39 | 39 | 38 | 39 | 39 |
Shares Outstanding (Diluted) | 41 | 41 | 41 | 40 | 40 | 41 |
Shares Change | -1.92% | 0.05% | 1.05% | 1.44% | -2.15% | 0.38% |
EPS (Basic) | 0.38 | 0.38 | 0.29 | 0.27 | 0.16 | 0.23 |
EPS (Diluted) | 0.36 | 0.37 | 0.28 | 0.25 | 0.16 | 0.22 |
EPS Growth | 6.51% | 32.14% | 12.00% | 56.25% | -27.27% | -71.80% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 29.24 | 11.93 | 1.32 | 19.12 | 4.85 | 2.75 |
Free Cash Flow Per Share | 0.72 | 0.29 | 0.03 | 0.47 | 0.12 | 0.07 |
Gross Margin | 57.47% | 57.52% | 59.40% | 61.63% | 60.99% | 62.71% |
Operating Margin | 8.47% | 8.08% | 7.69% | 8.18% | 6.05% | 8.99% |
Profit Margin | 4.81% | 5.53% | 5.02% | 5.60% | 4.48% | 7.80% |
Free Cash Flow Margin | 9.69% | 4.41% | 0.59% | 10.45% | 3.49% | 2.35% |
EBITDA | 55.8 | 50.45 | 42.62 | 36.84 | 24.03 | 21.84 |
EBITDA Margin | 18.50% | 18.67% | 19.00% | 20.13% | 17.31% | 18.66% |
D&A For EBITDA | 30.25 | 28.61 | 25.37 | 21.86 | 15.63 | 11.31 |
EBIT | 25.55 | 21.83 | 17.25 | 14.98 | 8.4 | 10.53 |
EBIT Margin | 8.47% | 8.08% | 7.69% | 8.18% | 6.05% | 8.99% |
Effective Tax Rate | 29.05% | 29.36% | 29.44% | 28.82% | 30.79% | 27.01% |